NMD PHARMA A/S
8Patents
8Active
8Granted
45Portfolio score
Filing activity: Jun 15, 2016 → Jun 19, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10934244B2 | Compounds for use in treating neuromuscular disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US10385028B2 | Compounds for the treatment of neuromuscular disorders | Chemistry; Metallurgy | 3 | Active |
| US11730714B2 | Compounds for the treatment of neuromuscular disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US11147788B2 | Compounds for the treatment of neuromuscular disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US11591284B2 | Compounds for the treatment of neuromuscular disorders | Chemistry; Metallurgy | 1 | Active |
| US12168643B2 | Compounds for the treatment of neuromuscular disorders | Chemistry; Metallurgy | 0 | Active |
| US12415771B2 | Compounds for the treatment of neuromuscular disorders | Chemistry; Metallurgy | 0 | Active |
| US12221425B2 | Process for the preparation of CIC-1 chloride channel inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.